Patent details
EP1744739 Title: USE OF TREPROSTINIL TO TREAT NEUROPATHIC DIABETIC FOOT ULCERS
Basic Information
- Publication number:
- EP1744739
- PCT Application Number:
- PCT/US/2005/012471
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP057356487
- PCT Publication Number:
- WO/2005/099680
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- USE OF TREPROSTINIL TO TREAT NEUROPATHIC DIABETIC FOOT ULCERS
- French Title of Invention:
- UTILISATION DE TREPROSTINILE POUR TRAITER DES ULCERES DIABETIQUES NEUROPATHIQUES DU PIED
- German Title of Invention:
- VERWENDUNG VON TREPROSTINIL ZUR BEHANDLUNG VON NEUROPATHISCHEN DIABETISCHEN FUSSGESCHWÜREN
- SPC Number:
Dates
- Filing date:
- 12/04/2005
- Grant date:
- 31/03/2010
- EP Publication Date:
- 31/03/2010
- PCT Publication Date:
- 27/10/2005
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 24/01/2007
- EP B1 Publication Date:
- 31/03/2010
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 12/04/2010
- Expiration date:
- 12/04/2025
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 12/04/2005
- Name:
- United Therapeutics Corporation
- Address:
- 1040 Spring Street Silver Spring, Maryland 20910, United States (US)
Inventor
1
- Name:
- WADE Michael
- Address:
- United States (US)
2
- Name:
- STROOTMAN Deborah
- Address:
- United States (US)
3
- Name:
- JEFFS Roger, Andrew
- Address:
- United States (US)
Priority
- Priority Number:
- 561157 P
- Priority Date:
- 12/04/2004
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61K 31/192;
| Filing date | Document type | Number of pages |
|---|